Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin

Dinesh B. Shenoy, Reshma J. D'Souza, Sandip B. Tiwari, N. Udupa

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The objective of this investigation was to develop an injectable, depot-forming drug delivery system for insulin based on microparticle technology to maintain constant plasma drug concentrations over prolonged period of time for the effective control blood sugar levels. Formulations were optimized with two well-characterized biodegradable polymers namely, poly(DL-lactide-co-glycolide) and poly-ε-caprolactone and evaluated in vitro for physicochemical characteristics, drug release in phosphate buffered saline (pH 7.4), and evaluated in vivo in streptozotocin-induced hypoglycemic rats. With a large volume of internal aqueous phase during w/o/w double emulsion solvent evaporation process and high molecular weight of the polymers used, we could not achieve high drug capture and precise control over subsequent release within the study period of 60 days. However, this investigation revealed that upon subcutaneous injection, the biodegradable depot-forming polymeric microspheres controlled the drug release and plasma sugar levels more efficiently than plain insulin injection. Preliminary pharmacokinetic evaluation exhibited steady plasma insulin concentration during the study period. These formulations, with their reduced frequency of administration and better control over drug disposition, may provide an economic benefit to the user compared with products currently available for diabetes control.

Original languageEnglish
Pages (from-to)555-563
Number of pages9
JournalDrug Development and Industrial Pharmacy
Volume29
Issue number5
DOIs
Publication statusPublished - 2003

Fingerprint

Microspheres
Suspensions
Insulin
Polymers
Pharmaceutical Preparations
Polyglactin 910
Injections
Plasmas
Drug and Narcotic Control
Subcutaneous Injections
Drug Delivery Systems
Streptozocin
Emulsions
Hypoglycemic Agents
Blood Glucose
Pharmacokinetics
Molecular Weight
Phosphates
Economics
Biodegradable polymers

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology
  • Molecular Medicine

Cite this

Shenoy, Dinesh B. ; D'Souza, Reshma J. ; Tiwari, Sandip B. ; Udupa, N. / Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin. In: Drug Development and Industrial Pharmacy. 2003 ; Vol. 29, No. 5. pp. 555-563.
@article{0bfb479308b546719279f63d20dd94eb,
title = "Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin",
abstract = "The objective of this investigation was to develop an injectable, depot-forming drug delivery system for insulin based on microparticle technology to maintain constant plasma drug concentrations over prolonged period of time for the effective control blood sugar levels. Formulations were optimized with two well-characterized biodegradable polymers namely, poly(DL-lactide-co-glycolide) and poly-ε-caprolactone and evaluated in vitro for physicochemical characteristics, drug release in phosphate buffered saline (pH 7.4), and evaluated in vivo in streptozotocin-induced hypoglycemic rats. With a large volume of internal aqueous phase during w/o/w double emulsion solvent evaporation process and high molecular weight of the polymers used, we could not achieve high drug capture and precise control over subsequent release within the study period of 60 days. However, this investigation revealed that upon subcutaneous injection, the biodegradable depot-forming polymeric microspheres controlled the drug release and plasma sugar levels more efficiently than plain insulin injection. Preliminary pharmacokinetic evaluation exhibited steady plasma insulin concentration during the study period. These formulations, with their reduced frequency of administration and better control over drug disposition, may provide an economic benefit to the user compared with products currently available for diabetes control.",
author = "Shenoy, {Dinesh B.} and D'Souza, {Reshma J.} and Tiwari, {Sandip B.} and N. Udupa",
year = "2003",
doi = "10.1081/DDC-120018644",
language = "English",
volume = "29",
pages = "555--563",
journal = "Drug Development and Industrial Pharmacy",
issn = "0363-9045",
publisher = "Informa Healthcare",
number = "5",

}

Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin. / Shenoy, Dinesh B.; D'Souza, Reshma J.; Tiwari, Sandip B.; Udupa, N.

In: Drug Development and Industrial Pharmacy, Vol. 29, No. 5, 2003, p. 555-563.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin

AU - Shenoy, Dinesh B.

AU - D'Souza, Reshma J.

AU - Tiwari, Sandip B.

AU - Udupa, N.

PY - 2003

Y1 - 2003

N2 - The objective of this investigation was to develop an injectable, depot-forming drug delivery system for insulin based on microparticle technology to maintain constant plasma drug concentrations over prolonged period of time for the effective control blood sugar levels. Formulations were optimized with two well-characterized biodegradable polymers namely, poly(DL-lactide-co-glycolide) and poly-ε-caprolactone and evaluated in vitro for physicochemical characteristics, drug release in phosphate buffered saline (pH 7.4), and evaluated in vivo in streptozotocin-induced hypoglycemic rats. With a large volume of internal aqueous phase during w/o/w double emulsion solvent evaporation process and high molecular weight of the polymers used, we could not achieve high drug capture and precise control over subsequent release within the study period of 60 days. However, this investigation revealed that upon subcutaneous injection, the biodegradable depot-forming polymeric microspheres controlled the drug release and plasma sugar levels more efficiently than plain insulin injection. Preliminary pharmacokinetic evaluation exhibited steady plasma insulin concentration during the study period. These formulations, with their reduced frequency of administration and better control over drug disposition, may provide an economic benefit to the user compared with products currently available for diabetes control.

AB - The objective of this investigation was to develop an injectable, depot-forming drug delivery system for insulin based on microparticle technology to maintain constant plasma drug concentrations over prolonged period of time for the effective control blood sugar levels. Formulations were optimized with two well-characterized biodegradable polymers namely, poly(DL-lactide-co-glycolide) and poly-ε-caprolactone and evaluated in vitro for physicochemical characteristics, drug release in phosphate buffered saline (pH 7.4), and evaluated in vivo in streptozotocin-induced hypoglycemic rats. With a large volume of internal aqueous phase during w/o/w double emulsion solvent evaporation process and high molecular weight of the polymers used, we could not achieve high drug capture and precise control over subsequent release within the study period of 60 days. However, this investigation revealed that upon subcutaneous injection, the biodegradable depot-forming polymeric microspheres controlled the drug release and plasma sugar levels more efficiently than plain insulin injection. Preliminary pharmacokinetic evaluation exhibited steady plasma insulin concentration during the study period. These formulations, with their reduced frequency of administration and better control over drug disposition, may provide an economic benefit to the user compared with products currently available for diabetes control.

UR - http://www.scopus.com/inward/record.url?scp=0037570800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037570800&partnerID=8YFLogxK

U2 - 10.1081/DDC-120018644

DO - 10.1081/DDC-120018644

M3 - Article

C2 - 12779285

AN - SCOPUS:0037570800

VL - 29

SP - 555

EP - 563

JO - Drug Development and Industrial Pharmacy

JF - Drug Development and Industrial Pharmacy

SN - 0363-9045

IS - 5

ER -